Showing results (31-40 of 75) with videos related to
Sort By:
Pageof 8
Journal of Psychiatric Research|November 26, 2010
Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapineBenedicto Crespo-Facorro, Rocío Pérez-Iglesias, Ignacio Mata, et al.Schizophrenia Research|April 15, 2008
Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosisIgnacio Mata, Rocio Perez-Iglesias, Jose Maria Pelayo-Teran, et al.Schizophrenia Research|October 3, 2009
Specific brain structural abnormalities in first-episode schizophrenia. A comparative study with patients with schizophreniform disorder, non-schizophrenic non-affective psychoses and healthy volunteersBenedicto Crespo-Facorro, Roberto Roiz-Santiáñez, Rocío Pérez-Iglesias, et al.Journal of Psychiatric Research|September 24, 2009
Insular cortex morphometry in first-episode schizophrenia-spectrum patients: Diagnostic specificity and clinical correlationsBenedicto Crespo-Facorro, Roberto Roiz-Santiáñez, Carlos Quintero, et al.Psychopharmacology|August 21, 2013
Treatment of first-episode non-affective psychosis: a randomized comparison of aripiprazole, quetiapine and ziprasidone over 1 yearBenedicto Crespo-Facorro, Victor Ortiz-Garcia de la Foz, Ignacio Mata, et al.Schizophrenia Research|November 30, 2004
Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate populationSusan Staddon, Maria J Arranz, Dalu Mancama, et al.Journal of Psychopharmacology (Oxford, England)|February 5, 2011
Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparisonBenedicto Crespo-Facorro, Rocío Pérez-Iglesias, Ignacio Mata, et al.Schizophrenia Research|May 7, 2013
Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: a 12-week randomized, flexible-dose, open-label trialBenedicto Crespo-Facorro, Victor Ortiz-García de la Foz, Ignacio Mata, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 21, 2007
Low-activity allele of Catechol-O-Methyltransferase (COMTL) is associated with increased lateral ventricles in patients with first episode non-affective psychosisBenedicto Crespo-Facorro, Roberto Roiz-Santiáñez, José María Pelayo-Terán, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 26, 2013
Prediction of acute clinical response following a first episode of non affective psychosis: results of a cohort of 375 patients from the Spanish PAFIP studyBenedicto Crespo-Facorro, Victor Ortiz-Garcia de la Foz, Rosa Ayesa-Arriola, et al.Pageof 8